IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
722.94
+93.43 (14.84%)
At close: Nov 3, 2025, 4:00 PM EST
722.33
-0.61 (-0.08%)
After-hours: Nov 3, 2025, 4:29 PM EST
IDEXX Laboratories Employees
IDEXX Laboratories had 11,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
11,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$378,856
Profits / Employee
$93,402
Market Cap
57.84B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11,000 | 0 | - |
| Dec 31, 2023 | 11,000 | 220 | 2.04% |
| Dec 31, 2022 | 10,780 | 430 | 4.15% |
| Dec 31, 2021 | 10,350 | 1,050 | 11.29% |
| Dec 31, 2020 | 9,300 | 100 | 1.09% |
| Dec 31, 2019 | 9,200 | 823 | 9.82% |
| Dec 31, 2018 | 8,377 | 777 | 10.22% |
| Dec 31, 2017 | 7,600 | 235 | 3.19% |
| Dec 31, 2016 | 7,365 | 565 | 8.31% |
| Dec 31, 2015 | 6,800 | 400 | 6.25% |
| Dec 31, 2014 | 6,400 | 700 | 12.28% |
| Dec 31, 2013 | 5,700 | 300 | 5.56% |
| Dec 31, 2012 | 5,400 | 300 | 5.88% |
| Dec 31, 2011 | 5,100 | 300 | 6.25% |
| Dec 31, 2010 | 4,800 | 0 | - |
| Dec 31, 2009 | 4,800 | 100 | 2.13% |
| Dec 31, 2008 | 4,700 | 0 | - |
| Dec 31, 2007 | 4,700 | 800 | 20.51% |
| Dec 31, 2006 | 3,900 | 600 | 18.18% |
| Dec 31, 2005 | 3,300 | 305 | 10.18% |
| Dec 31, 2004 | 2,995 | 522 | 21.11% |
| Dec 31, 2003 | 2,473 | 292 | 13.39% |
| Dec 31, 2002 | 2,181 | 11 | 0.51% |
| Dec 31, 2001 | 2,170 | -80 | -3.56% |
| Dec 31, 2000 | 2,250 | 200 | 9.76% |
| Dec 31, 1999 | 2,050 | -50 | -2.38% |
| Dec 31, 1998 | 2,100 | 0 | - |
| Dec 31, 1997 | 2,100 | 585 | 38.61% |
| Dec 31, 1996 | 1,515 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IDXX News
- 5 hours ago - IDEXX Laboratories, Inc. (IDXX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 hours ago - Idexx Stock Pops on Earnings. Pet Health Is Booming. - Barrons
- 5 hours ago - Idexx Laboratories Extends Rally Following Upbeat Q3 Earnings, Outlook - Benzinga
- 8 hours ago - IDEXX raises annual forecasts as pet owners spend more on preventive care - Reuters
- 10 hours ago - IDEXX Laboratories Announces Third Quarter Results - Business Wire
- 15 hours ago - IDEXX Laboratories Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Benzinga
- 26 days ago - IDEXX Laboratories to Release 2025 Third Quarter Financial Results - Business Wire
- 27 days ago - IDEXX Laboratories Elects Karen Peacock to Board of Directors - Business Wire